TISENTO THERAPEUTICS Trademark

Trademark Overview


On Thursday, August 24, 2023, a trademark application was filed for TISENTO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TISENTO THERAPEUTICS trademark a serial number of 98148750. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, September 24, 2024. This trademark is owned by Tisento Therapeutics Inc.. The TISENTO THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of mitochondrial diseases or disorders

Pharmaceutical research and development; Conducting pharmaceutical clinical trials for others in the field of mitochondrial disease; Pharmaceutical product development
tisento therapeutics

General Information


Serial Number98148750
Word MarkTISENTO THERAPEUTICS
Filing DateThursday, August 24, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of a series of four light purple rays on the left and a series of six purple rays on the right, with a faint white bullseye design appearing in the background, and with the left set of rays appearing shorter and the right set of rays appearing longer and in varying shades of purple that darken towards the outer edge, with the wording "TISENTO THERAPEUTICS" to the right of the ray design with "TISENTO" in green above "THERAPEUTICS" in gray.
Goods and ServicesPharmaceutical preparations for the treatment of mitochondrial diseases or disorders
Indication of Colors claimedThe color(s) light purple, purple, green, gray, and white is/are claimed as a feature of the mark.
NOT AVAILABLETHERAPEUTICS
Translation of Words in MarkThe English translation of TISENTO in the mark is I HEAR YOU.
Goods and ServicesPharmaceutical research and development; Conducting pharmaceutical clinical trials for others in the field of mitochondrial disease; Pharmaceutical product development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 25, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTisento Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, March 18, 2024ASSIGNED TO EXAMINER
Monday, August 28, 2023NEW APPLICATION ENTERED
Monday, September 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 29, 2024NON-FINAL ACTION WRITTEN
Friday, March 29, 2024NON-FINAL ACTION E-MAILED
Friday, March 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 26, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 26, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED